These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27432150)

  • 1. AAOM Clinical Practice Statement: Subject: Clinical management of cancer therapy-induced salivary gland hypofunction and xerostomia.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Sep; 122(3):310-2. PubMed ID: 27432150
    [No Abstract]   [Full Text] [Related]  

  • 2. Xerostomia and hypofunction of the salivary glands in cancer therapy.
    Jensen SB; Pedersen AM; Reibel J; Nauntofte B
    Support Care Cancer; 2003 Apr; 11(4):207-25. PubMed ID: 12673459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients.
    Jensen SB; Vissink A; Limesand KH; Reyland ME
    J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in understanding of toxicities of treatment for head and neck cancer.
    Logan RM
    Oral Oncol; 2009 Oct; 45(10):844-8. PubMed ID: 19467918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of post-radiotherapy salivary glands.
    Cheng SC; Wu VW; Kwong DL; Ying MT
    Br J Radiol; 2011 May; 84(1001):393-402. PubMed ID: 21511748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term oral effects in patients treated with radiochemotherapy for head and neck cancer.
    Deboni AL; Giordani AJ; Lopes NN; Dias RS; Segreto RA; Jensen SB; Segreto HR
    Support Care Cancer; 2012 Nov; 20(11):2903-11. PubMed ID: 22410861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Questionable validity of the systematic review and meta-analysis by Lovelace et al. on management of radiotherapy-induced salivary hypofunction and xerostomia in patients with oral or head and neck cancer.
    Mercadante V; Lodi G; Porter S; Fedele S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):120-1. PubMed ID: 25482550
    [No Abstract]   [Full Text] [Related]  

  • 8. [Radiation xerostomia].
    Branchi R; Pagni L; Bernardini UD; Marra N
    Stomatol Mediterr; 1989; 9(4):297-301. PubMed ID: 2517979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry mouth and salivary gland hypofunction, Part II: Etiology and patient evaluation.
    Sreebny LM
    Compendium; 1988 Sep; 9(8):630-1, 634-5, 638 passim. PubMed ID: 3267471
    [No Abstract]   [Full Text] [Related]  

  • 10. Salivary gland sparing in the treatment of head and neck cancer.
    Scrimger R
    Expert Rev Anticancer Ther; 2011 Sep; 11(9):1437-48. PubMed ID: 21929317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xerostomia in head and neck malignancy.
    Porter SR; Fedele S; Habbab KM
    Oral Oncol; 2010 Jun; 46(6):460-3. PubMed ID: 20403723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MASCC/ISOO Clinical Practice Statement: Clinical assessment of salivary gland hypofunction and xerostomia in cancer patients.
    Hong C; Epstein JB; Jensen SB; Gueiros LA; van Leeuwen SJM; Kandwal A; Vissink A; Elad S
    Support Care Cancer; 2024 Jul; 32(8):551. PubMed ID: 39048727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xerostomia: recognition and management of hypofunction of the salivary glands.
    Garg AK; Kirsh ER
    Compend Contin Educ Dent; 1995 Jun; 16(6):574, 576-84; quiz 586. PubMed ID: 8620388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary gland and associated complications in head and neck cancer therapy.
    Kumar S; Ram S; Navazesh M
    J Calif Dent Assoc; 2011 Sep; 39(9):639-47. PubMed ID: 22034798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.
    Jensen SB; Pedersen AM; Vissink A; Andersen E; Brown CG; Davies AN; Dutilh J; Fulton JS; Jankovic L; Lopes NN; Mello AL; Muniz LV; Murdoch-Kinch CA; Nair RG; Napeñas JJ; Nogueira-Rodrigues A; Saunders D; Stirling B; von Bültzingslöwen I; Weikel DS; Elting LS; Spijkervet FK; Brennan MT;
    Support Care Cancer; 2010 Aug; 18(8):1039-60. PubMed ID: 20237805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy induced xerostomia: mechanisms, diagnostics, prevention and treatment--evidence based up to 2013.
    Kałużny J; Wierzbicka M; Nogala H; Milecki P; Kopeć T
    Otolaryngol Pol; 2014; 68(1):1-14. PubMed ID: 24484943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline.
    Mercadante V; Jensen SB; Smith DK; Bohlke K; Bauman J; Brennan MT; Coppes RP; Jessen N; Malhotra NK; Murphy B; Rosenthal DI; Vissink A; Wu J; Saunders DP; Peterson DE
    J Clin Oncol; 2021 Sep; 39(25):2825-2843. PubMed ID: 34283635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xerostomia: diagnosis and management.
    Greenspan D
    Oncology (Williston Park); 1996 Mar; 10(3 Suppl):7-11. PubMed ID: 8723427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xerostomia.
    Delli K; Spijkervet FK; Kroese FG; Bootsma H; Vissink A
    Monogr Oral Sci; 2014; 24():109-25. PubMed ID: 24862599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.
    Chambers MS; Garden AS; Kies MS; Martin JW
    Head Neck; 2004 Sep; 26(9):796-807. PubMed ID: 15350026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.